🕒 Last update: loading…

Stock BiomX Inc. PHGE

BiomX Inc. — Investlytic score 0/5 on the five criteria.

-
-
0/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 0/5 criteria met.

  • ❌ Price trend failed
  • ❌ Growth failed
  • ❌ Debt failed
  • ❌ P/E failed
  • ❌ Correction failed

Price trend

Overall trend (8 years): insufficient progression (less than x1.5).

Price change 2019 → 2020: -34.12%

Price change 2020 → 2021: -74.92%

Price change 2021 → 2022: -88.31%

Price change 2022 → 2023: 49.73%

Price change 2023 → 2024: -73.93%

Price change 2024 → 2025: -86.52%

Price change 2025 → 2026: -90.15%

Price change 2026 (year to date): -91.39%

Financial growth

Revenue CAGR (8 years): N/A

Earnings CAGR (8 years): N/A

Growth status: insufficient data or negative trend.

Debt

Debt-to-equity ratio: 1436000.00

Debt/equity > 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: -0.08

P/E > 25.0 (maximum threshold).

Correction (6 months)

Current correction: 97.54% from the high over 6 months.

Excessive correction (> 20.0%).

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, model verdict (buy, watch, sell) and details of the 5 criteria · visible with a free account.

02

Price trend

Price & trend

Interactive chart →
Loading chart…
03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

+

Dividends and earnings

BiomX Inc.: dividend history, last distributions, stock splits and earnings releases.

No known dividend for this company.

Earnings releases

DatePublished EPSExpected EPSSurprise
24/03/2026-67.60-46.10n/a
13/11/2025-5.51-3.20n/a
13/08/20253.61-6.27n/a
19/05/2025-3.30-4.20n/a
02/04/2025-8.55-16.50n/a
14/11/2024-5.89-6.00n/a

Stock splits

DateOperation
09/09/2026reverse split: 1 share for 10
25/11/2025reverse split: 1 share for 19
26/08/2024reverse split: 1 share for 10

Factual data: ex-dividend history and earnings calendar, as of 21/11/2026. A past dividend does not guarantee the next one.

+

PEA and practical information

PEA eligibility
no
head office outside the EU and EEA
Listing exchange
NYSE American
IPO: 13/03/2019
ISIN code
US09090D3017
Workforce
52
full-time employees
Chief executive
Jonathan Eitan Solomon MBA

Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.

?

Frequently asked questions about BiomX Inc.

Is BiomX Inc. stock eligible for the French PEA?

No: the company is headquartered outside the European Union and the European Economic Area (ISIN US09090D3017).

How many employees does BiomX Inc. have?

52 full-time employees according to the latest published profile.

Who runs BiomX Inc.?

Jonathan Eitan Solomon MBA is the company's chief executive.